Drug Trial Radar · NCT06223880
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Last checked: Nov 19, 2026Latest source record: Jan 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
350
Planned (sponsor's estimate)
Start
Dec 27, 2023
Primary completion
Mar 2026
Study completion Mar 2026
Sponsor
- Lead sponsor
- Axsome Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 25, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with major depressive disorder (MDD) who have responded to treatment with AXS-05.
Conditions
- Major Depressive Disorder
Interventions
AXS-05Drug
Up to 10 weeks in open-label period; Up to 26 weeks in double-blind period
BupropionDrug
Up to 26 weeks in double-blind period
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time from randomization to relapse of depressive symptomsTime frame: up to 26 weeks
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Bellflower, California · Recruiting
Clinical Research Site
Lafayette, California · Recruiting
Clinical Research Site
Oceanside, California · Recruiting
Clinical Research Site
Redlands, California · Recruiting
Clinical Research Site
Riverside, California · Recruiting
Clinical Research Site
San Diego, California · Recruiting
Clinical Research Site
Upland, California · Recruiting
Clinical Research Site
Brandon, Florida · Recruiting
Clinical Research Site
Doral, Florida · Recruiting
Clinical Research Site
Hialeah, Florida · Recruiting
Clinical Research Site
Jacksonville, Florida · Recruiting
Clinical Research Site
Miami, Florida · Recruiting
Clinical Research Site
Orlando, Florida · Recruiting
Clinical Research Site
Orlando, Florida · Recruiting
Clinical Research Site
Orlando, Florida · Recruiting
Clinical Research Site
Atlanta, Georgia · Recruiting
Clinical Research Site
Chicago, Illinois · Recruiting
Clinical Research Site
Overland Park, Kansas · Recruiting
Clinical Research Site
New Orleans, Louisiana · Recruiting
Clinical Research Site
Boston, Massachusetts · Recruiting
Clinical Research Site
Saint Charles, Missouri · Recruiting
Clinical Research Site
Las Vegas, Nevada · Recruiting
Clinical Research Site
Cherry Hill, New Jersey · Recruiting
Clinical Research Site
Toms River, New Jersey · Recruiting
Clinical Research Site
Brooklyn, New York · Recruiting
Clinical Research Site
Mount Kisco, New York · Recruiting
Clinical Research Site
New York, New York · Recruiting
Clinical Research Site
Staten Island, New York · Recruiting
Clinical Research Site
Hickory, North Carolina · Recruiting
Clinical Research Site
Cincinnati, Ohio · Recruiting
Clinical Research Site
Edmond, Oklahoma · Recruiting
Clinical Research Site
Oklahoma City, Oklahoma · Recruiting
Clinical Research Site
Portland, Oregon · Recruiting
Clinical Research Site
Memphis, Tennessee · Recruiting
Clinical Research Site
Dallas, Texas · Recruiting
Clinical Research Site
Dallas, Texas · Recruiting
Clinical Research Site
Friendswood, Texas · Recruiting
Clinical Research Site
San Antonio, Texas · Recruiting
Clinical Research Site
Wichita Falls, Texas · Recruiting
Clinical Research Site
Everett, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.